Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: The impact of screening and amniocentesis (CROSBI ID 133649)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Brajenović-Milić, Bojana ; Prpić, Igor ; Petrović, Oleg ; Ristić, Smiljana ; Brumini, Gordana ; Kapović, Miljenko The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: The impact of screening and amniocentesis // Maternal and child health journal, 12 (2008), 620-623. doi: 10.1007/s10995-007-0272'6

Podaci o odgovornosti

Brajenović-Milić, Bojana ; Prpić, Igor ; Petrović, Oleg ; Ristić, Smiljana ; Brumini, Gordana ; Kapović, Miljenko

engleski

The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: The impact of screening and amniocentesis

Objectives To investigate the prevalence of live birth Down syndrome (DS) in the region of Primorsko-goranska County (PGC) in Croatia from 1996 to 2005 and to evaluate the impact of second-trimester maternal serum screening (MSS) and amniocentesis on live birth DS prevalence. Methods Study was based on databases from the Department of Gynecology and Obstetrics, University Hospital Centre Rijeka, the Department of Biology and Medical Genetics, School of Medicine, University of Rijeka, and the Croatian National Institute of Public Health. The regional policy of prenatal diagnosis for DS includes amniocentesis for pregnant women aged 35 or over and MSS for younger women. We estimated live birth and total prevalence of DS and measured the proportion of pregnant women using MSS and amniocentesis. Trends of live birth and total prevalence of DS were tested by linear regression analysis. Results The live birth prevalence of DS was 1.4/1000 in the period 1996-2005. A decreasing, but nonsignificant, trend of prevalence was observed over time (p=0.577). Women aged 35 or over represented 11.6% of all pregnant women included in the study. The proportion of women who had MSS was 33.9%. The proportion who underwent amniocentesis was 6.1%. Conclusions No marked decrease in prevalence of live birth DS was observed in the region of PGC during the last ten years. The usage of MSS and amniocentesis was too low to have any significant impact on live birth DS prevalence. Women˘s, as well as physician˘s, knowledge and attitudes towards prenatal diagnosis of DS should be evaluated.

Down Syndrome; live birth prevalence; maternal serum screening; amniocentesis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12

2008.

620-623

objavljeno

1092-7875

10.1007/s10995-007-0272'6

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost